Bionano Genomics Inc (BNGO) Stock Price, Quote & News

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-resu...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858 888 7600

Website: bionano.com

Address:

9540 Towne Centre Drive, Suite 100, San Diego, United States

sloshua Aug. 19 at 1:54 PM

$BNGO

0 · Reply

Dennizz Aug. 17 at 1:19 PM

$PGABF 🇺🇸 Could this be one of Europe’s most overlooked MedTech microcaps? $PGABF A tiny Swedish precision-medicine company Prostatype valued at only $5 million has developed a fully commercialized genomic test for prostate cancer, and is now awaiting a potentially transformational Medicare reimbursement decision in the U.S before year end🔥 $BNGO $INO $TNXP $ATOS.X

1 · Reply

juanagustin2086 Aug. 15 at 6:29 AM

$BNGO

0 · Reply

Marcobecco Aug. 13 at 3:42 PM

$BNGO

0 · Reply

tokenhead Aug. 13 at 1:48 AM

$BNGO yes fuc ski boy..

0 · Reply

Snow120 Aug. 12 at 6:09 PM

$BNGO where is motherfucking Erik? He is still CEO ???? Fuck him 🖕🏻🖕🏻🖕🏻🖕🏻

0 · Reply

JinUzuki Aug. 11 at 7:37 PM

$BNGO There's no hope here. There's nothing that is going to push this back up higher.

0 · Reply

LeeSo Aug. 10 at 9:46 PM

$BNGO Out of my $71.2k investment, I can barely get a decent breakfast…!!! Lol $4500 a share is my average. I keep it as a souvenir! SMH

1 · Reply

StocktwitsEarnings Aug. 10 at 9:25 PM

$BNGO Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.64 up 67.84% YoY • Reported revenue of -$6.67M down -199.10% YoY

0 · Reply

EarningsInsider Aug. 10 at 9:15 PM

https://www.marketbeat.com/earnings/reports/2026-8-10-bionano-genomics-inc-stock/ $BNGO Bionano Genomics Earnings Transcript

0 · Reply

Bionano Genomics Earnings Call Transcript: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Bionano Genomics Earnings release: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Bionano Genomics Quarterly report: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Bionano Genomics Slides: Q2 2026

Jul 27, 2026, 4:05 PM EDT - 22 days ago

Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026

2026-06-24T12:45:32.000Z - 2 months ago

Bionano Genomics appoints Alex Hastie as chief scientific officer

Jun 24, 2026, 8:30 AM EDT - 2 months ago

Bionano Announces Hiring of Chief Scientific Officer

2026-06-18T12:39:35.000Z - 2 months ago

Bionano Genomics announces studies featuring OGM at 2026 conference

Jun 18, 2026, 8:00 AM EDT - 2 months ago

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

Jun 11, 2026, 8:00 AM EDT - 2 months ago

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

May 28, 2026, 8:00 AM EDT - 2 months ago

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

2026-05-26T15:31:13.000Z - 3 months ago

Bionano Genomics announces OGM study of T-cell acute lymphoblastic leukemia

May 26, 2026, 8:00 AM EDT - 3 months ago

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Slides: Q1 2026

May 13, 2026, 4:05 PM EDT - 3 months ago

Bionano Reports First Quarter 2026 Results and Provides a Business Update

2026-05-08T23:01:48.000Z - 3 months ago

Bionano Genomics files $400M mixed securities shelf

May 8, 2026, 8:00 AM EDT - 3 months ago

Bionano Genomics Registration statement: Registration filing

2026-05-07T00:20:18.000Z - 3 months ago

Bionano Genomics CEO Erik Holmlin to step down, Al Luderer to succeed

May 6, 2026, 4:30 PM EDT - 3 months ago

Bionano Announces Leadership Transition

May 5, 2026, 8:00 AM EDT - 3 months ago

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

Apr 29, 2026, 4:05 PM EDT - 3 months ago

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

2026-04-13T10:18:13.000Z - 4 months ago

Bionano Genomics price target lowered to $6 from $7 at H.C. Wainwright

Apr 2, 2026, 8:00 AM EDT - 4 months ago

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Apr 2, 2026, 8:00 AM EDT - 4 months ago

Bionano Genomics Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 4 months ago

Bionano Genomics Proxy statement: Proxy filing

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Earnings Call Transcript: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Annual report: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Earnings release: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Slides: Q4 2025

2026-03-23T20:16:27.000Z - 5 months ago

Bionano Genomics reports Q4 revenue $7.95M vs. $8.16M last year

2026-03-23T20:15:56.000Z - 5 months ago

Bionano Genomics sees Q1 revenue $6.5M-$6.7M

Mar 23, 2026, 4:05 PM EDT - 5 months ago

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Mar 9, 2026, 4:05 PM EDT - 5 months ago

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

2026-02-27T13:11:08.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium Day 4 highlights

Feb 27, 2026, 8:00 AM EST - 6 months ago

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

2026-02-26T13:37:50.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium Day 3 highlights

Feb 26, 2026, 8:00 AM EST - 6 months ago

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

Feb 25, 2026, 8:00 AM EST - 6 months ago

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

2026-02-24T13:11:39.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium Day 1 highlights

Feb 24, 2026, 8:00 AM EST - 6 months ago

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

2026-02-09T14:10:50.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium 2026

Feb 9, 2026, 9:05 AM EST - 6 months ago

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

2026-02-04T13:21:16.000Z - 7 months ago

Bionano Genomics announces publication on OGM, gene editing technology

Feb 4, 2026, 8:00 AM EST - 7 months ago

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

2026-01-12T13:17:13.000Z - 7 months ago

Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M

2025-12-11T13:26:28.000Z - 8 months ago

Bionano Genomics recaps advances in OGM showcased at AMP 2025

Dec 3, 2025, 8:00 AM EST - 9 months ago

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

2025-11-24T11:15:34.000Z - 9 months ago

Bionano Genomics price target lowered to $7 from $11 at H.C. Wainwright

Nov 13, 2025, 4:30 PM EST - 9 months ago

Bionano Genomics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Bionano Genomics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Bionano Genomics Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Bionano Genomics Slides: Q3 2025

Nov 13, 2025, 4:01 PM EST - 9 months ago

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

2025-11-06T13:33:02.000Z - 10 months ago

Bionano Genomics announces publication of study on OGM

Nov 6, 2025, 8:00 AM EST - 10 months ago

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Oct 30, 2025, 4:05 PM EDT - 10 months ago

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

2025-10-15T14:15:47.000Z - 11 months ago

Bionano Genomics participates in a conference call with H.C. Wainwright

Oct 15, 2025, 10:00 AM EDT - 11 months ago

Bionano Genomics Transcript: H.C. Wainwright @ Home Event

Oct 7, 2025, 8:00 AM EDT - 11 months ago

Bionano to Participate in the H.C. Wainwright @ Home Event

Sep 17, 2025, 5:00 PM EDT - 11 months ago

Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering

Sep 16, 2025, 7:00 AM EDT - 1 year ago

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Sep 15, 2025, 7:00 AM EDT - 1 year ago

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Sep 11, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Registration statement: Registration Filing

Sep 8, 2025, 3:00 PM EDT - 1 year ago

Bionano Genomics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 8:00 AM EDT - 1 year ago

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q2 2025

Aug 14, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Aug 13, 2025, 3:00 PM EDT - 1 year ago

Bionano Genomics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 31, 2025, 4:05 PM EDT - 1 year ago

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

Jun 11, 2025, 1:00 PM EDT - 1 year ago

Bionano Genomics Transcript: AGM 2025

May 19, 2025, 8:00 AM EDT - 1 year ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q1 2025

May 14, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 13, 2025, 8:00 AM EDT - 1 year ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 7, 2025, 4:01 PM EDT - 1 year ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 2, 2025, 9:30 AM EDT - 1 year ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q4 2024

Mar 31, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 14, 2025, 8:00 AM EDT - 1 year ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 13, 2025, 9:00 AM EDT - 1 year ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Jan 22, 2025, 4:05 PM EST - 1 year ago

Bionano Announces Effective Date of Reverse Stock Split

Jan 15, 2025, 1:00 PM EST - 1 year ago

Bionano Genomics Transcript: EGM 2025

Jan 8, 2025, 7:00 AM EST - 1 year ago

Bionano Genomics Registration statement: Registration Filing

Jan 6, 2025, 4:30 PM EST - 1 year ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 7:00 AM EST - 1 year ago

Bionano Genomics Registration statement: Registration Filing

Dec 31, 2024, 3:26 PM EST - 1 year ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 23, 2024, 8:30 AM EST - 1 year ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Dec 19, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Dec 5, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Dec 5, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Nov 25, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Slides: Q3 2024

Nov 13, 2024, 4:01 PM EST - 1 year ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

sloshua Aug. 19 at 1:54 PM

$BNGO

0 · Reply

Dennizz Aug. 17 at 1:19 PM

1 · Reply

juanagustin2086 Aug. 15 at 6:29 AM

$BNGO

0 · Reply

Marcobecco Aug. 13 at 3:42 PM

$BNGO

0 · Reply

tokenhead Aug. 13 at 1:48 AM

$BNGO yes fuc ski boy..

0 · Reply

Snow120 Aug. 12 at 6:09 PM

$BNGO where is motherfucking Erik? He is still CEO ???? Fuck him 🖕🏻🖕🏻🖕🏻🖕🏻

0 · Reply

JinUzuki Aug. 11 at 7:37 PM

$BNGO There's no hope here. There's nothing that is going to push this back up higher.

0 · Reply

LeeSo Aug. 10 at 9:46 PM

$BNGO Out of my $71.2k investment, I can barely get a decent breakfast…!!! Lol $4500 a share is my average. I keep it as a souvenir! SMH

1 · Reply

StocktwitsEarnings Aug. 10 at 9:25 PM

$BNGO Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.64 up 67.84% YoY • Reported revenue of -$6.67M down -199.10% YoY

0 · Reply

EarningsInsider Aug. 10 at 9:15 PM

https://www.marketbeat.com/earnings/reports/2026-8-10-bionano-genomics-inc-stock/ $BNGO Bionano Genomics Earnings Transcript

0 · Reply

Polymorpher Aug. 10 at 8:50 PM

$BNGO Stable sales, strong demand, but manufacturing still not up to speed, creating limitations. Cash runway is still 1Q 2027.

0 · Reply

JinUzuki Aug. 10 at 8:04 PM

$BNGO Earnings… and no one cares… amazing!

0 · Reply

JinUzuki Aug. 8 at 1:21 PM

$BNGO FLYING!

0 · Reply

Caaron8695 Aug. 4 at 10:23 PM

$BNGO i lost 30k with investing in BNGO! BUYERS BEWARE they will reverse split you to nothing not even worth the gamble I.M.O. Think im lying just go to the Max on all your stocks find out wich stocks have been reverse splitting not even worth the Time no longer holding reverse split stocks forward splits are the best

0 · Reply

JinUzuki Aug. 4 at 2:14 PM

$BNGO I didn’t even notice, but this shit hit $1.00 on Friday!? BHAHAHAHAHA… that’s 0.00167c pre-splits…

0 · Reply

Peaceouty Jul. 31 at 9:34 PM

$SPCX Around the end of next week you’re gonna have regrets. $BNGO

0 · Reply

JinUzuki Jul. 31 at 1:40 PM

$BNGO This really is as bad as IBIO... what a fucking scam

0 · Reply

focafoca99 Jul. 27 at 8:26 PM

$BNGO to report Q2 2026 earnings on Aug 10 via webcast. https://www.rapidticker.com/news/bngo-bionano-to-report-second-quarter-eb443e

0 · Reply

Pinto72 Jul. 22 at 4:29 AM

$BNGO Which one is @Landsman and which one is @MessengerOfMoistville ? 🤣🤣🤣🤣🤣

1 · Reply

Imallears Jul. 17 at 11:01 AM

$BNGO Wow! Sad.

1 · Reply

madore13 Jul. 17 at 1:12 AM

$PKK.CSE $XWEL $BNGO $AYTU $LMRMF i told you when it was around .08 can now at .16 it will at least double again so dont waste you time

0 · Reply

madore13 Jul. 17 at 1:08 AM

$PKKFF $XWEL $BNGO $AYTU $LMRMF i told you when it was around .08 can now at .16 it will at least double again so dont waste you time

1 · Reply

Market Cap	14.02M
Revenue (ttm)	28.51M
Net Income (ttm)	-26.40M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-92.60%
Debt to Equity Ratio	0.00

Volume	206,705
Avg Vol	126,726
Day's Range	N/A - N/A
Shares Out	11.78M
Stochastic %K	74%
Beta	1.63
Analysts	Strong Sell
Price Target	$5.00